The long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin for the treatment of type 2 diabetes in China
Article in Health Economics Review (April 2024)
The most recent citing publications are shown below. View all 500 publications that cite this research output on Dimensions.
Article in Health Economics Review (April 2024)
Article in PharmacoEconomics - Open (February 2024)
Article in Diabetes Technology & Therapeutics (February 2024)